ICU Medical (NASDAQ:ICUI) Price Target Raised to $158.00 at Raymond James

ICU Medical (NASDAQ:ICUI) had its price objective boosted by Raymond James from $135.00 to $158.00 in a research note released on Thursday, Benzinga reports. Raymond James currently has an outperform rating on the medical instruments supplier’s stock.

Separately, Needham & Company LLC reiterated a hold rating on shares of ICU Medical in a research report on Thursday. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, ICU Medical has a consensus rating of Moderate Buy and a consensus target price of $138.33.

ICU Medical Trading Up 0.9 %

ICUI traded up $1.36 on Thursday, hitting $152.71. 567,547 shares of the company were exchanged, compared to its average volume of 281,822. The firm has a fifty day simple moving average of $121.24 and a two-hundred day simple moving average of $108.10. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.09 and a current ratio of 2.61. ICU Medical has a 12 month low of $78.28 and a 12 month high of $153.55. The stock has a market capitalization of $3.72 billion, a PE ratio of -62.33 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.56. The business had revenue of $596.50 million for the quarter, compared to analyst estimates of $556.64 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. ICU Medical’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the company earned $1.58 EPS. Sell-side analysts expect that ICU Medical will post 3.5 earnings per share for the current year.

Insider Activity

In other news, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total value of $295,425.50. Following the completion of the transaction, the vice president now owns 4,482 shares in the company, valued at approximately $645,901.02. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, COO Christian B. Voigtlander sold 12,539 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $103.95, for a total value of $1,303,429.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total value of $295,425.50. Following the completion of the transaction, the vice president now owns 4,482 shares of the company’s stock, valued at approximately $645,901.02. The disclosure for this sale can be found here. Insiders sold a total of 14,889 shares of company stock worth $1,630,340 in the last quarter. 6.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ICUI. SG Americas Securities LLC purchased a new position in ICU Medical during the fourth quarter valued at $106,000. New York State Teachers Retirement System raised its stake in ICU Medical by 6.8% during the fourth quarter. New York State Teachers Retirement System now owns 27,566 shares of the medical instruments supplier’s stock valued at $2,749,000 after buying an additional 1,761 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in ICU Medical by 32.6% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 104,253 shares of the medical instruments supplier’s stock valued at $10,398,000 after buying an additional 25,626 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new position in ICU Medical during the fourth quarter valued at $496,000. Finally, WCM Investment Management LLC raised its stake in ICU Medical by 37.5% during the fourth quarter. WCM Investment Management LLC now owns 242,808 shares of the medical instruments supplier’s stock valued at $24,223,000 after buying an additional 66,221 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.